Drug Approved for Advanced Kidney Cancer
Inlyta is for people who don’t respond to another drugContinue Reading
Inlyta is for people who don’t respond to another drugContinue Reading
Study found lower risk of developing disease for people taking these cholesterol-cutting drugsContinue Reading
But it’s not clear yet how helpful the molecular exam will be, experts sayContinue Reading
Mutations in two genes found in tumors appear to fuel their growthContinue Reading
National targets for breast, cervical and colon malignancies still not being metContinue Reading
Sex, smoking associated with raised risk of transmission, researchers reportContinue Reading
However, it’s not clear which patients would benefit, studies findContinue Reading
No risk factors by middle age is ‘the fountain of youth for your heart’Continue Reading
Regular Pap tests, HPV vaccine go a long way in warding off the disease, experts sayContinue Reading
Women with BRCA1, BRCA2 have higher risk for the disease, but prognosis might be betterContinue Reading
Typically used for an enlarged prostate, it could prevent need for aggressive treatmentContinue Reading
Conflict fires up molecules related to inflammation, researchers reportContinue Reading
Sunburn in childhood a major risk factor for skin cancer, experts noteContinue Reading
Researchers say they’ve identified three more genomic regions associated with the diseaseContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.